BioFormulate Live Europe 2026 (#BFL) | BioPharma/Big Pharma/ Acads

Europe’s formulation, stability, drug-delivery leaders get together in London to shape the next generation of high-performance biologics. A high-impact leadership forum solving the toughest challenges in biologics formulation and delivery ‍BioFormulate Live 2026 brings Europe’s formulation, stability, and drug-delivery leaders together for an intensive deep dive into the science shaping tomorrow’s biologics. Across 3 focused streams - RNA Therapeutics & Development, Vaccine Innovation, and Biologics Formulation & Delivery - the programme explores pioneering systems, stability strategies, and next-gen delivery technologies redefining biopharmaceutical development. Europe’s landscape for biologics formulation and delivery is evolving at unprecedented speed. With RNA medicines, advanced vaccines, and complex biologics becoming central to global health, the pressure has never been greater to engineer drug products that are more stable, more manufacturable, and more patient-centric. BioFormulate Live 2026 is designed precisely for that mission. Co-located with: Biologics Manufacturing UK & BioOutsourcing Europe